logo

For the Inventor, By the Inventor

New York, NY, United States of America

Axsome Therapeutics, Inc.


USPTO Granted Patents = 134



Trademarks = 20

Forward Citations = 5,577

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Herriot Tabuteau (134 out of 407 patents)


Core Competencies:
Pharmaceutical Compositions
Meloxicam
Reboxetine
Narcolepsy Treatment
Bupropion
Cysteine
Tolfenamic Acid
Enantiomerically Enriched Bupropion
Dosage Forms
Drug Delivery
Therapeutic Applications

134 patents:

1. 12485176 - Pharmaceutical compositions comprising meloxicam (2025-12-02),
2. 12478678 - Pharmaceutical compositions comprising meloxicam (2025-11-25),
3. 12472258 - Pharmaceutical compositions comprising meloxicam (2025-11-18),
4. 12472257 - Pharmaceutical compositions comprising meloxicam (2025-11-18),
5. 12472256 - Pharmaceutical compositions comprising meloxicam (2025-11-18),
6. 12472255 - Pharmaceutical compositions comprising meloxicam (2025-11-18),
7. 12447155 - Use of reboxetine to treat narcolepsy (2025-10-21),
8. 12370196 - Pharmaceutical compositions comprising meloxicam (2025-07-29),
9. 12357697 - Pharmaceutical compositions comprising bupropion and cysteine (2025-07-15),
10. 12357640 - Pharmaceutical compositions comprising meloxicam (2025-07-15),
11. 12268693 - Pharmaceutical compositions comprising a tolfenamic acid (2025-04-08),
12. 12246023 - Use of reboxetine to treat narcolepsy (2025-03-11),
13. 12156914 - Pharmaceutical compositions comprising bupropion and cysteine (2024-12-03),
14. 12128052 - Pharmaceutical compositions comprising meloxicam (2024-10-29),
15. 12115165 - Use of reboxetine to treat narcolepsy (2024-10-15),
Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the lives of patients with neurological disorders. The company's product pipeline is designed to address a range of central nervous system (CNS) conditions, such as major depressive disorder, treatment-resistant depression, migraine, and Alzheimer's disease. With a commitment to innovation and clinical excellence, Axsome Therapeutics aims to bring transformative treatments to patients in need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
134 Patents

#76 in New York, NY

#166 in New York

#2,780 in US

#5,841 in the World

...
New York, NY, United States of America

Axsome Therapeutics, Inc.

Forward Citations = 5,577

4 inventors:

goldMedal Herriot Tabuteau (134 out of 407 patents)

Please report any incorrect information to support@idiyas.com
Loading…